DIN 02284227 — NEXAVAR 200 MG
NEXAVAR is a tablet of Sorafenib marketed by BAYER INC. The full Sorafenib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02284227
- Brand name
- NEXAVAR
- Active ingredient
- Sorafenib
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BAYER INC
- Health Canada status
- MARKETED
- Drug class
- Multikinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.